Post-transcriptional expression of DMT1 in the heart of rat

Journal of Cellular Physiology

Volumn 196, Issue 1, 2003, Pages 124-130

  Ke, Ya ^a   Chen, Yin Yin ^a   Chang, Yan Zhong ^a,b   Duan, Xiang Lin ^a,b   Ho, Kwok Ping ^a   Jiang, De He ^a   Wang, Kui ^a   Qian, Zhong Ming ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b HEBEI NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEME; IRON; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TRANSFERRIN; TRANSFERRIN RECEPTOR;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEART HYPERTROPHY; HEART INJURY; HEART MUSCLE CELL; IRON DEFICIENCY; IRON INTAKE; IRON METABOLISM; IRON RESPONSIVE ELEMENT; IRON TRANSPORT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TISSUE LEVEL; WESTERN BLOTTING;

AGING; ALTERNATIVE SPLICING; ANIMALS; CATION TRANSPORT PROTEINS; DIET; GENE EXPRESSION REGULATION; IRON; IRON-BINDING PROTEINS; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0038283184     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10284     Document Type: Article

References (40)

1. Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Loutradi A, Hatziliami A, Joussef J, Rombos J, Loukopoulos D. 2001. Cardiac involvement in thalassemia intermedia: A multicenter study. Blood 97:3411-3416.
2. Berenshtein E, Mayer B, Goldberg C, Kitrossky N, Chevion M. 1997. Patterns of mobilization of copper and iron following myocardial ischemia: Possible predictive criteria for tissue injury. J Mol Cell Cardiol 29:3025-3034.
3. Chen YY, Ho KP, Xia Q, Qian ZM. 2002. Hydrogen peroxide enhances iron-induced injury in isolated heart and ventricular cardiomyocyte in rats. Mol Cell Biochem 231:61-68.
4. de Valk B, Marx JJ. 1999. Iron, atherosclerosis, and ischemic heart disease. Arch Int Med 159:1542-1548.
5. Duffy SJ, Keaney JF, Jr., Holbrook M, Gokce N, Swerdloff PL, Frei B, Vita JA. 2001. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104:151-156.
6. Fleming MD, Trenor CC III, Su MA, Foernzler D, Beier DR, Dietrich WF, Andrews NC. 1997. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16:383-386.
7. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:482-488.
8. Haidari M, Javadi E, Sanati A, Hajilooi M, Ghanbili J. 2001. Association of increased ferritin with premature coronary stenosis in men. Clin Chem 47:1666-1672.
9. Hentze MW, Kuhn LC. 1996. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93:8175-8182.
10. Horwitz LD, Rosenthal EA. 1999. Iron-mediated cardiovascular injury. Vasc Med 4:93-99.
11. Horwitz LD, Sherman NA, Kong Y, Pike AW, Gobin J, Fennessey PV, Horwitz MA. 1998. Lipophilic siderophores of Mycobacterium tuberculosis prevent cardiac reperfusion injury. Proc Nat Acad Sci USA 95:5263-5268.
12. Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, Utsumi H, Hamasaki N, Takeshita A. 2001. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Cir Res 88:529-535.
13. Jeffrey GP, Basclain KA, Allen TL. 1996. Molecular regulation of transferrin receptor and ferritin expression in the rat gastrointestinal tract. Gastroenterology 110:790-800.
14. Klausner RD, Rouault TA, Harford JB. 1993. Regulating the fate of mRNA: The control of cellular iron metabolism. Cell 72:19-28.
15. Klipstein-Grobusch K, Koster JF, Grobbee DE, Lindemans J, Boeing H, Hofman A, Witteman JC. 1999. Serum ferritin and risk of myocardial infarction in the elderly: The Rotterdam Study. Am J Clin Nutr 69:1231-1236.
16. Lee PL, Gelbart T, West C, Halloran C, Beutler E. 1998. The human Nramp2 gene: Characterization of the gene structure, alternative splicing, promoter region, and polymorphisms. Blood Cell Mol Dis 24:199-215.
17. Link G, Pinson A, Hershko C. 1985. Heart cells in culture: A model of myocardial iron overload and chelation. J Lab Clin Med 106:147-153.
18. Minotti G, Recalcati S, Mordente A, Liberi G, Calafiore AM, Mancuso C, Preziosi P, Cairo G. 1998. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J 12:541-552.
19. Minotti G, Cairo G, Monti E. 1999. Role of iron in anthracycline cardiotoxicity: New tunes for an old song? FASEB J 13:199-212.
20. Nieto N, Greenwel P, Friedman SL, Zhang F, Dannenberg AJ, Cederbaum AI. 2000. Ethanol and arachidonic acid increase alpha 2(I) collagen expression in rat hepatic stellate cells overexpressing cytochrome P450 2E1. J Biol Chem 275:20136-20145.
21. Parkes JG, Liu Y, Sirna JB, Templeton DM. 2000. Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts. J Mol Cell Cardiol 32:233-246.
22. Pereira AC, Cuoco MA, Mota GF, da Silva FF, Freitas HF, Bocchi EA, Soler JM, Mansur AJ, Krieger JE. 2001. Hemochromatosis gene variants in patients with cardiomyopathy. Am J Cardiol 88:388-391.
23. Qian ZM, Tang PL. 1995. Mechanisms of iron uptake by mammalian cells. Biochim Biophys Acta 1269:205-214.
24. Qian ZM, Wang Q. 1998. Expression of iron transport proteins and excessive iron accumulation of iron in the brain in neurodegenerative disorders. Brain Res Rev 127:257-267.
25. Qian ZM, Xiao DS, Tang PL, Yao FYD, Liao QK. 1999. The increased expression of transferrin receptor on the membrane of erythroblast in strenuous exercised rats. J Appl Physiol 87:523-529.
26. Qian ZM, Xiao DS, Ke Y, Liao QK. 2001. Increased nitric oxide is one of the causes of changes of iron metabolism in strenuously exercised rats. Am J Physiol 280:R739-R743.
27. Su MA, Trenor CC, Fleming JC, Templeton DM. 1998. The G185R mutation disrupts function of the iron transporter Nramp2. Blood 92:2157-2163.
28. Sullivan JL, Zacharski LR. 2001. Hereditary haemochromatosis and the hypothesis that iron depletion protects against ischemic heart disease. Eur J Clin Invest 31:375-377.
29. Tabuchi M, Yoshimori T, Yamaguchi K, Yoshida T, Kishi F. 2000. Human NRAMP2/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in HEp-2 cells. J Biol Chem 275:22220-22228.
30. Taher A, Sheikh-Taha M, Koussa S, Inati A, Neeman R, Mourad F. 2001. Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients. Eur J Haematol 67:30-34.
31. Tandy S, Williams M, Leggett A, Lopez-Jimenez M, Dedes M, Ramesh B, Srai SK, Sharp P. 2000. Nramp2 expression is associated with pH-dependent iron uptake across the apical membrane of human intestinal Caco-2 cells. J Biol Chem 275:1023-1029.
32. Trinder D, Oates PS, Thomas C, Sadleir J, Morgan EH. 2000. Localisation of divalent metal transporter 1 (DMT1) to the microvillus membrane of rat duodenal enterocytes in iron deficiency, but to hepatocytes in iron overload. Gut 46:270-276.
33. 2+ channel modifiers: Possible implications in iron overload. Circ Res 84:1302-1309.
34. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT. 1998. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97:1461-1466.
35. Tzonou A, Lagiou P, Trichopoulou A, Tsoutsos V, Trichopoulos D. 1998. Dietary iron and coronary heart disease risk: A study from Greece. Am J Epidemiol 147:161-166.
36. Wardrop SL, Richardson DR. 1999. The effect of intracellular iron concentration and nitrogen monoxide on NRAMP2 expression and non-transferrin-bound iron uptake. Eur J Biochem 263:41-49.
37. Xu MF, Ho S, Qian ZM, Tang PL. 2001a. Melatonin protects against cardiac toxicity of doxorubicin in rat. J Pineal Res 31:301-307.
38. Xu MF, Tang PL, Qian ZM, Ashraf M. 2001b. Effects by doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sci 68:889-901.
39. Yeh KY, Yeh M, Watkins JA, Rodriguez-Paris J, Glass J. 2000. Dietary iron induces rapid changes in rat intestinal divalent metal transporter expression. Am J Physiol Gastrointest Liver Physiol 279:G1070-G1079.
40. Zaman AK, Fujii S, Sawa H, Goto D, Ishimori N, Watano K, Kaneko T, Furumoto T, Sugawara T, Sakuma I, Kitabatake A, Sobel BE. 2001. Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice. Circulation 103:3123-3128.